首页> 外文期刊>North American Journal of Medical Sciences >Protective effect of Livactine against CCl4 and paracetamol induced hepatotoxicity in adult Wistar rats
【24h】

Protective effect of Livactine against CCl4 and paracetamol induced hepatotoxicity in adult Wistar rats

机译:利伐汀对成年Wistar大鼠CCl4和扑热息痛诱导的肝毒性的保护作用

获取原文
           

摘要

Background:Liver disease has become one of the serious health problems as it is exposed to many kinds of xenobiotics and therapeutic agents. Moreover the rapidly growing morbidity and mortality from liver disease are attributable to the increasing number of chemical compounds and environmental pollution. Unfortunately, so far, in the modern era of medicine there is no specific treatment to counter the menacing impact of these dreaded diseases. Many polyherbal formulations are used widely to treat these disorders. Livactine is a polyherbal formulation and is claimed to be useful in jaundice and biliary dysfunctions. Most of these formulations do not have standard and approved reports stating their pharmacological action or therapeutic efficacy. Therefore, there is a need for experimental confirmation of the pharmacological effects of this formulation. The rationale behind the selection of carbon tetrachloride is due to its free radical mechanism based liver injury, and paracetamol is consumed widely by the human population and it is also a potential liver hazard.Aim:To evaluate the anti-hepatotoxic activity of Livactine against carbon tetrachloride & paracetamol induced toxicity in rats.Material and Methods:Albino rats of Wistar strain were used to evaluate the hepatoprotective activity of Livactine against carbon tetrachloride & paracetamol induced toxicity. Liver damage was assessed by estimating various biochemical parameters such as serum glutamate oxaloacetate transaminase, serum glutamate pyruvate transaminase, lactate dehydrogenase, alkaline phosphatase, acid phosphatase, total bilirubin, and total protein. The results of the rats treated with Livactine were compared with that of Liv-52.Results:Livactine showed significant dose dependent hepatoprotective effect by reducing elevated serum enzyme levels when compared to that of Liv-52.Conclusion:Our findings confirm that the formulation was found to be effective pharmacologically at higher dose against carbon tetrachloride and paracetamol induced hepatotoxic models and were comparable to that of Liv-52. The resultant hepatoprotective activity of Livactine could be due to its free radical scavenging property of the ingredients.
机译:背景:肝病已经暴露于多种异源生物和治疗剂中,已成为严重的健康问题之一。此外,由于肝脏疾病的发病率和死亡率的迅速增长归因于化合物数量的增加和环境污染。不幸的是,到目前为止,在现代医学时代,还没有针对这些可怕疾病的威胁性的特殊治疗方法。许多多草药制剂被广泛用于治疗这些疾病。利伐汀是一种多草药制剂,据称可用于黄疸和胆道功能障碍。这些制剂中的大多数没有标准和批准的报告来说明其药理作用或治疗功效。因此,需要对该制剂的药理作用进行实验确认。选择四氯化碳的基本原理是由于其基于自由基机制的肝损伤,对乙酰氨基酚被人们广泛消耗,并且它也是潜在的肝脏危害。目的:评估利伐汀对碳的抗肝毒性活性材料与方法:以Wistar菌株的白化病大鼠为研究对象,评估利伐汀对四氯化碳及对乙酰氨基酚的毒性。通过估计各种生化参数,例如血清谷氨酸草酰乙酸转氨酶,血清谷氨酸丙酮酸转氨酶,乳酸脱氢酶,碱性磷酸酶,酸性磷酸酶,总胆红素和总蛋白质,来评估肝损害。将利伐汀治疗的大鼠与Liv-52进行比较。结果:与Liv-52相比,利伐汀通过降低升高的血清酶水平具有显着的剂量依赖性肝保护作用。发现在较高剂量下对四氯化碳和扑热息痛诱导的肝毒性模型在药理学上有效,并且与Liv-52相当。产生的利伐汀的肝保护活性可能是由于其成分的自由基清除性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号